Nuclear Localization of Cell-Penetrating Peptides Is Dependent on Endocytosis Rather Than Cytosolic Delivery in CHO Cells
- 3 February 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 6 (2), 337-344
- https://doi.org/10.1021/mp800239p
Abstract
The nuclear localization of various cell penetrating peptides (CPPs), including Tat [47−57], YG(R)9, YG(K)9, and model amphipathic peptide (MAP), was examined and correlated with the endocytosis and cytosolic transfer efficiency in CHO cells. The results showed that the internalization of the amphipathic peptide, MAP, was much higher than that of the other cationic CPPs tested. During subcellular fractionation analysis, MAP was only found in the vesicular fraction and was not detectable in the cytosol, similar to the intracellular localization of YG(K)9 as previously determined. This localization pattern differs greatly from the cationic CPPs oligoarginine and Tat, which were previously found primarily in the cytosol. Both quantitative and qualitative analysis of MAP showed high nuclear localization, with staining in perinuclear vesicles. On the other hand, YG(R)9 was found to be excluded from the nucleus. Lysosomotropic amines altered the nuclear localization of the CPPs tested, and the change was correlated with the release of degradation products from the treated cells. These results suggest that highly endocytosed CPPs such as MAP may be more suitable for nuclear drug delivery applications than peptides such as Tat and YG(R)9 that are efficiently delivered to the cytosol.Keywords
This publication has 32 references indexed in Scilit:
- Peptides in DNA delivery: current insights and future directionsDrug Discovery Today, 2008
- Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative studyBiochemical Journal, 2007
- Cell Penetrating Peptides: Intracellular Pathways and Pharmaceutical PerspectivesPharmaceutical Research, 2007
- Cellular uptake mechanisms and potential therapeutic utility of peptidic cell delivery vectors: Progress 2001–2006Medicinal Research Reviews, 2006
- RECENT APPROACHES TO INTRACELLULAR DELIVERY OF DRUGS AND DNA AND ORGANELLE TARGETINGAnnual Review of Biomedical Engineering, 2006
- Evidence that membrane transduction of oligoarginine does not require vesicle formationExperimental Cell Research, 2005
- Quantitative comparison of membrane transduction and endocytosis of oligopeptidesBiochemical and Biophysical Research Communications, 2003
- Arginine containing peptides as delivery vectorsAdvanced Drug Delivery Reviews, 2002
- Cellular uptake of an α-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocyticallyBiochimica et Biophysica Acta (BBA) - Biomembranes, 1998
- Emerging Targeting ConceptsNuclear Import of DNA—The Ultimate Targeting in Gene TherapyJournal of Drug Targeting, 1997